{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:23:35Z","timestamp":1785198215845,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T00:00:00Z","timestamp":1518998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.tranon.2018.02.008","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T00:59:29Z","timestamp":1520470769000},"page":"546-551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors"],"prefix":"10.1016","volume":"11","author":[{"given":"Sarah","family":"Jonsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Idahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2018.02.008_bb0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.tranon.2018.02.008_bb0010","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","article-title":"Ovarian carcinoma pathology and genetics: recent advances","volume":"40","author":"Gilks","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0015","first-page":"1","article-title":"An immunohistochemical comparison between low grade and high grade ovarian serous carcinomas","volume":"207","author":"O'Neill","year":"2005","journal-title":"J Pathol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0020","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/modpathol.2011.85","article-title":"Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis","volume":"24","author":"Yemelyanova","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2015.07.100","article-title":"Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma","volume":"139","author":"Novak","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0030","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2559.2007.02682.x","article-title":"High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour","volume":"50","author":"O'Neill","year":"2007","journal-title":"Histopathology"},{"key":"10.1016\/j.tranon.2018.02.008_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/IGC.0b013e3181d6de3f","article-title":"An immunohistochemical comparison of P53 and Bcl-2 as apoptotic and MIB1 as proliferative markers in low-grade and high-grade ovarian serous carcinomas","volume":"20","author":"Mishra","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.tranon.2018.02.008_bb0040","first-page":"967","article-title":"The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors","volume":"53","author":"Giurgea","year":"2012","journal-title":"Romanian J Morphol Embryol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0045","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0050","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","article-title":"Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models","volume":"24","author":"Perets","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2018.02.008_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0065","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.3023","article-title":"TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions","volume":"226","author":"Kuhn","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0070","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/infdis\/159.6.1105","article-title":"Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection","volume":"159","author":"Patton","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tranon.2018.02.008_bb0075","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0015-0282(16)47489-3","article-title":"Host response to primary Chlamydia trachomatis infection of the fallopian tube in pig-tailed monkeys","volume":"40","author":"Patton","year":"1983","journal-title":"Fertil Steril"},{"key":"10.1016\/j.tranon.2018.02.008_bb0080","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","article-title":"Viral and bacterial aetiologies of epithelial ovarian cancer","volume":"31","author":"Shanmughapriya","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.tranon.2018.02.008_bb0085","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1086\/652402","article-title":"Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies","volume":"201","author":"Geisler","year":"2010","journal-title":"J Infect Dis"},{"issue":"10 9","key":"10.1016\/j.tranon.2018.02.008_bb0090","first-page":"e00203","article-title":"Chlamydia trachomatis: the Persistent Pathogen","volume":"24","author":"Witkin","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0095","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/457036b","article-title":"Cancer: Inflaming metastasis","volume":"457","author":"Mantovani","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2018.02.008_bb0100","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2018.02.008_bb0105","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.90.9.3998","article-title":"Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro","volume":"90","author":"Beatty","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tranon.2018.02.008_bb0110","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1128\/iai.62.9.3705-3711.1994","article-title":"Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence","volume":"62","author":"Beatty","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.tranon.2018.02.008_bb0115","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1128\/IAI.69.4.2442-2447.2001","article-title":"Persistent Chlamydia trachomatis infections resist apoptotic stimuli","volume":"69","author":"Dean","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.tranon.2018.02.008_bb0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.187.4.487","article-title":"Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation","volume":"187","author":"Fan","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.tranon.2018.02.008_bb0125","series-title":"WHO classification of tumours of female reproductive organs","year":"2014"},{"key":"10.1016\/j.tranon.2018.02.008_bb0130","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1538-7836.2009.03305.x","article-title":"Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis","volume":"7","author":"Dieude","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tranon.2018.02.008_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00395-010-0135-y","article-title":"Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability","volume":"106","author":"Erbel","year":"2011","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1099\/mic.0.27625-0","article-title":"The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents","volume":"151","author":"Pickett","year":"2005","journal-title":"Microbiology"},{"key":"10.1016\/j.tranon.2018.02.008_bb0145","doi-asserted-by":"crossref","first-page":"71.e1","DOI":"10.1016\/j.ajog.2009.07.042","article-title":"Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human papillomavirus, and polyomavirus are not detectable in human tissue with epithelial ovarian cancer, borderline tumor, or benign conditions","volume":"202","author":"Idahl","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0150","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1515\/cclm-2014-1202","article-title":"Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banks","volume":"53","author":"Ahmad-Nejad","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.tranon.2018.02.008_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0160","first-page":"117","article-title":"Could epithelial ovarian cancer be associated with chlamydial infection?","volume":"28","author":"Wong","year":"2007","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0165","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tranon.2018.02.008_bb0170","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/824627","article-title":"Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors","volume":"2011","author":"Idahl","year":"2011","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0175","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1128\/jcm.23.5.924-928.1986","article-title":"Persistence of chlamydial antibodies after pelvic inflammatory disease","volume":"23","author":"Puolakkainen","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tranon.2018.02.008_bb0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1757-2215-7-30","article-title":"Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer","volume":"7","author":"Bodzek","year":"2014","journal-title":"J Ovarian Res"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652331730428X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652331730428X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:36:06Z","timestamp":1761834966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652331730428X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S193652331730428X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2018.02.008","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chlamydia trachomatis, Chlamydial Heat Shock Protein 60 and Anti-Chlamydial Antibodies in Women with Epithelial Ovarian Tumors","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2018.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of SOCIETY. CC BY-NC-ND 4.0","name":"copyright","label":"Copyright"}]}}